Finance

Morgan Cheatham, partner and head of healthcare and life sciences at Breyer Capital, provides highlights of the venture capital firm's strategy when funding emerging technologies and the risks associated with backing these innovations.

The healthcare engagement company, which focuses on vulnerable populations, acquired the food delivery company, thanks to a $47.5 million investment.

As AI technology continues to evolve, Abhinav Shashank, Innovaccer CEO, says IT leaders must stay focused on ensuring that all AI tools are ethically trained, tested and deployed and that their desired outcomes are clearly defined.

While they were originally tools for administrative documentation, EHRs now prioritize streamlining clinicians' workflows and enhancing care delivery, says Sandra Johnson, SVP of client services at CliniComp.

The company plans to offer an aggregate of 7.9 million shares of its common stock with an initial public offering price between $18 and $20 per share.

The company will use the funds to grow its team, expedite commercial deployments with pharma companies and enhance Willis, its new clinical outcome assessment platform.  

The company began trading on the NYSE today under the ticker symbol HNGE, opening at $39.25, up 23% from its IPO price of $32, and closing at $37.56 per share.

According to Ryne Natzke, TrustCommerce's chief revenue officer, health systems can better meet patients' expectations by accepting digital wallets and leveraging AI tools to identify patients who need customized payment plans.

The platform will be offered via the firm's Venture Studio, which helps healthcare startups gain commercial traction, connect with target buyers and form partnerships with health systems.  

The combination will allow healthcare and life sciences companies to respond more efficiently to research questions.